Detailed guidance on the registration of NMPA Class II medical devices in China,
分类:行业新闻 发布时间:2024-08-16 15:58:17
If you need more specific details or assistance with any part of the process, let me know!

Registering a Class II medical device with the NMPA (National Medical Products Administration) in China involves several key steps. Here’s a detailed guide to help you through the process:

1. Determine Device Classification

1.1 Classification Confirmation:

  • Confirm that the device falls into Class II based on its risk level and intended use according to Chinese regulations.

2. Prepare Required Documentation

2.1 Application Form:

  • Complete the NMPA application form for Class II medical devices.

2.2 Product Description:

  • Provide a detailed description of the device, including its intended use, design, specifications, and performance characteristics.

2.3 Technical Documentation:

  • Design and Manufacturing Information: Detailed information on the device’s design, manufacturing process, and quality control measures.
  • Risk Management Documentation: Include risk assessment and management documentation.
  • Clinical Data: Clinical trial data might be required, particularly if there is no existing data or if the device is novel or has significant variations.
  • Quality Management System (QMS) Certification: Proof of compliance with QMS standards (e.g., ISO 13485).
  • Product Testing Reports: Provide reports from accredited testing laboratories demonstrating compliance with Chinese standards for performance, safety, and biocompatibility.

2.4 Labeling and Instructions:

  • Include translations of the device’s labeling, instructions for use, and other relevant user information into Chinese.

3. Submission Process

3.1 Online Submission:

  • Submit the application and supporting documents through the NMPA’s online submission system.

3.2 Physical Submission:

  • Provide physical copies of the application and documents to the NMPA office if required.

4. Review and Evaluation

4.1 Initial Review:

  • NMPA will review the application for completeness and adherence to regulatory requirements.

4.2 Technical Review:

  • The NMPA will perform a detailed review of the technical documentation, including performance and safety data.

4.3 On-site Inspection:

  • An inspection of the manufacturing facility may be required to ensure compliance with Good Manufacturing Practices (GMP).

4.4 Clinical Trial Review:

  • Evaluate clinical data submitted with the application. Additional clinical trials in China may be required depending on the device.

5. Fees

5.1 Application Fee:

  • Pay the application fee, which varies depending on the type and complexity of the device.

5.2 Review Fee:

  • Additional fees for the review process.

5.3 Testing Fees:

  • Fees related to product testing and inspections if applicable.

6. Approval and Issuance

6.1 Approval Notification:

  • Once the review process is complete and all requirements are met, you will receive an approval notification from the NMPA.

6.2 Issuance of Certificate:

  • The NMPA will issue the registration certificate for the Class II medical device.

7. Post-Approval Requirements

7.1 Regulatory Compliance:

  • Ensure ongoing compliance with Chinese regulations and standards.

7.2 Reporting Obligations:

  • Report any adverse events or issues related to the device to the NMPA as required.

7.3 Renewal and Updates:

  • Periodically renew the registration certificate as required and submit applications for significant changes or updates to the device.

8. Additional Considerations

8.1 Local Representation:

  • Engage a local regulatory consultant or agent to facilitate the registration process.

8.2 Translation:

  • Ensure that all documents are accurately translated into Chinese.

8.3 Regulatory Changes:

  • Stay informed about changes in NMPA regulations and guidelines to ensure compliance.

If you need more specific details or assistance with any part of the process, let me know!

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn

1(10).jpg